Skip to main content
Venus Medtech (Hangzhou) Inc. logo

Venus Medtech (Hangzhou) Inc. — Investor Relations & Filings

Ticker · 2500 ISIN · CNE100003PJ8 HKEX Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2024-09-19 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 2500

About Venus Medtech (Hangzhou) Inc.

http://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc. is an innovation-driven medical device company specializing in the research, development, manufacturing, and commercialization of transcatheter solutions for structural heart diseases. The company focuses on bioprosthetic heart valves, establishing a comprehensive pipeline that addresses aortic, pulmonary, mitral, and tricuspid valve diseases. Its product portfolio includes transcatheter aortic valve replacement (TAVR) solutions, and it is committed to addressing unmet demand in TPVR and TMVR. The company also develops solutions for hypertension, such as renal artery denervation ablation, and related surgical accessory products. Its products are commercialized globally, reaching over 60 countries and regions across Asia, Europe, and the Americas.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR USE AT THE 2024 FIRST CLASS MEETING OF HOLDERS OF H SHARES
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for the 2024 first class meeting of holders of H shares of Venus Medtech (Hangzhou) Inc. It includes instructions for appointing a proxy to vote on resolutions at the meeting, including amendments to the Articles of Association and rules of procedures, and a mandate to repurchase shares. The document is not a report or announcement of financial results, nor is it a voting results declaration. It is a solicitation of votes from shareholders for a meeting, which fits the definition of Proxy Solicitation & Information Statement (PSI). The document length (7173 characters) and content confirm it is the proxy form itself, not just an announcement of a meeting or report publication.
2024-09-19 English
PROXY FORM FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for use at the 2024 First Extraordinary General Meeting of Venus Medtech (Hangzhou) Inc. It includes instructions for shareholders to appoint proxies to vote on resolutions at the meeting, including election of a supervisor, amendments to articles of association, and mandates to issue or repurchase shares. This is a solicitation of shareholder votes and related information for a general meeting, not the meeting materials themselves or the voting results. Therefore, it fits the definition of Proxy Solicitation & Information Statement (PSI). The document length is 7703 characters, which is consistent with a detailed proxy form rather than a brief announcement or a full report.
2024-09-19 English
NOTICE OF 2024 FIRST CLASS MEETING OF HOLDERS OF UNLISTED FOREIGN SHARES
Regulatory Filings Classification · 95% confidence The document is a notice for a 2024 first class meeting of holders of unlisted foreign shares of Venus Medtech (Hangzhou) Inc. It details the date, location, agenda, and procedural notes for the meeting, including resolutions to be considered and voted upon. The document is a formal announcement inviting shareholders to attend and vote at the meeting, not the actual meeting materials, minutes, or results. It does not contain financial statements, management discussion, or detailed report content. The document is a notice of a shareholder meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting itself and not the solicitation materials or voting results, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement. The document length is about 6,000 characters, which is consistent with a notice rather than a full report or presentation. Therefore, the best fit is Regulatory Filings (RNS).
2024-09-19 English
NOTICE OF 2024 FIRST CLASS MEETING OF HOLDERS OF H SHARES
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for a 2024 first class meeting of holders of H shares of Venus Medtech (Hangzhou) Inc. It includes details about the meeting date, location, agenda items (special resolutions), proxy voting instructions, and shareholder registration. The document is a formal announcement inviting shareholders to attend and vote on specific resolutions, including amendments to the Articles of Association and granting a mandate to repurchase shares. There are no financial statements, management discussion, or detailed financial data presented. The document is not a report itself but a notice of a shareholder meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-09-19 English
NOTICE OF 2024 FIRST EXTRAORDINARY GENERAL MEETING
AGM Information Classification · 95% confidence The document is a notice for the 2024 First Extraordinary General Meeting (EGM) of Venus Medtech (Hangzhou) Inc. It includes details about the meeting date, location, agenda items such as election of a supervisor, amendments to articles of association and procedural rules, and mandates for share issuance and repurchase. The document is a formal announcement inviting shareholders to attend and vote at the EGM. It does not contain financial statements, audit information, or detailed management discussion. It is not a report but a meeting notice. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during general meetings, including extraordinary ones.
2024-09-19 English
(1) PROPOSED APPOINTMENT OF SHAREHOLDERS' REPRESENTATIVE SUPERVISOR (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR THE GENERAL MEETI
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a circular from the board of Venus Medtech (Hangzhou) Inc. regarding the 2024 First Extraordinary General Meeting and related class meetings. It includes detailed proposals such as appointment of a shareholders' representative supervisor, amendments to articles of association and procedural rules, general mandates to issue and repurchase shares, and notices of meetings. The document contains proxy forms and detailed information to enable shareholders to make informed decisions and vote on resolutions. It is not a financial report, earnings release, or audit report, but rather a comprehensive communication to shareholders about governance and meeting matters. This fits the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings.
2024-09-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.